Necrox-5 methanesulfonate

Modify Date: 2024-01-09 16:54:28

Necrox-5 methanesulfonate Structure
Necrox-5 methanesulfonate structure
Common Name Necrox-5 methanesulfonate
CAS Number 1383718-29-3 Molecular Weight 645.808
Density N/A Boiling Point N/A
Molecular Formula C27H39N3O9S3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Necrox-5 methanesulfonate


NecroX-5 is a derivative of the NecroX, reduces intracellular calcium concentration, and possesses anti-inflammatory and anti-cancer activity.

 Names

Name NecroX-5
Synonym More Synonyms

 Necrox-5 methanesulfonate Biological Activity

Description NecroX-5 is a derivative of the NecroX, reduces intracellular calcium concentration, and possesses anti-inflammatory and anti-cancer activity.
Related Catalog
Target

Calcium channel[1]

In Vitro NecroX-5 (10 or 40 μM) inhibits breast cancer cell migration, which is correlated with mitoROS reduction, and mediated by AKT inhibition. NecroX-5 (10 μM) decreases intracellular calcium concentration in 4T1 cells by blocking Ca2+ influx, which mediated the inhibition of cell migration, AKT downregulation and the reduction of mitochondrial ROS levels[1]. NecroX-5 (10 µM) treatment for 24 h, effectively decreases the increased TNFα, TGFβ1, pSmad2 and the expression of Dcn in LPS-stimulated H9C2 cells[2].
In Vivo NecroX-5 (2.5 mg/kg, everyday other day) inhibits breast cancer cell metastasis in TUBO-P2J tumour-bearing mice[1].
References

[1]. Park JH, et al. NecroX-5 prevents breast cancer metastasis by AKT inhibition via reducing intracellular calcium levels. Int J Oncol. 2017 Jan;50(1):185-192.

[2]. Thu VT, et al. NecroX-5 exerts anti-inflammatory and anti-fibrotic effects via modulation of the TNFα/Dcn/TGFβ1/Smad2 pathway in hypoxia/reoxygenation-treated rat hearts. Korean J Physiol Pharmacol. 2016 May;20(3):305-14.

 Chemical & Physical Properties

Molecular Formula C27H39N3O9S3
Molecular Weight 645.808
Exact Mass 645.184814
Storage condition 2-8℃

 Synonyms

1H-Indol-7-amine, 5-[(1,1-dioxido-4-thiomorpholinyl)methyl]-2-phenyl-N-[(tetrahydro-2H-pyran-4-yl)methyl]-, methanesulfonate (1:2)
5-[(1,1-Dioxido-4-thiomorpholinyl)methyl]-2-phenyl-N-(tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-7-amine methanesulfonate (1:2)